Skip to main content
Elsevier

Advances in Nanocarriers for Biofilm-Associated Infections

From Research to Clinical Practice

  • 1st Edition - April 1, 2027
  • Latest edition
  • Editors: Neeraj Mishra, Kuttiappan Anitha, Sumel Ashique
  • Language: English

Advances in Nanocarriers for Biofilm-Associated Infections: From Research to Clinical Practice addresses the critical challenge of treating biofilm-associated infections, which… Read more

End of Summer Sale

Save up to 30% off

Bright savings for research, study, and discovery

Shop the summer sale

Description

Advances in Nanocarriers for Biofilm-Associated Infections: From Research to Clinical Practice addresses the critical challenge of treating biofilm-associated infections, which are resistant to conventional antibiotics due to their protective microbial communities. This reference compiles cutting-edge research on nanocarriers, including nanoparticles, liposomes, dendrimers, and polymeric micelles, emphasizing their design and application to penetrate biofilms and enhance antimicrobial delivery. The comprehensive content covers biofilm formation, resistance mechanisms, and multidrug resistance, followed by detailed chapters on nanocarrier synthesis, functionalization, and therapeutic efficacy. Clinical and translational aspects are examined through case studies on chronic wounds, medical device infections, and respiratory biofilms, alongside regulatory hurdles and future research directions. The book features contributions from international experts, providing a multidisciplinary perspective on nanotechnology’s role in infection control.

It equips researchers, clinicians, and pharmaceutical professionals to understand complex biofilm biology, apply novel drug delivery systems, and navigate clinical challenges, ultimately supporting the development of improved treatments for persistent biofilm-related infections.

Key features

  • Explores nanocarrier technologies targeting biofilm-associated infections
  • Bridges research and clinical applications of nanocarriers in infection control
  • Highlights strategies to overcome antibiotic resistance using nanotechnology
  • Discusses regulatory and translational challenges in nanocarrier therapies
  • Presents future perspectives and innovative approaches in biofilm treatment

Readership

Medical researchers; microbiologists; nanomedicine scientists; infectious disease specialists; clinicians

Table of contents

1. Introduction to Biofilm-Associated Infections

2. Mechanisms of Biofilm Resistance

3. Biofilms and multidrug resistance (MDR) in infections

4. Nanocarriers. Fundamentals and Applications

5. Design and Synthesis of Nanocarriers for Biofilm Penetration

6. Nanoparticles in Targeted Therapy for Biofilm-Associated Infections

7. Liposomal Nanocarriers in Biofilm Treatment

8. Dendrimers as Nanocarriers in Biofilm Control

9. Polymeric Micelles for Biofilm-Associated Infections

10. Nanocarrier Strategies for Overcoming Antibiotic Resistance

11. Nanocarriers in Biofilm-Associated Infections. Clinical Challenges, Regulatory Hurdles, and Translational Perspectives

12. Nanocarriers in the Treatment of Medical Device-Associated Infections

13. Nanocarriers in Chronic Wound Management

14. Nanotechnology in Respiratory Infections and Biofilm Control

15. Hurdles and challenges (clinical as well as regulatory) for applications nanocarriers in biofilm-associated infections

16. Clinical Practice of Biofilm-Associated Infections

17. Future Perspectives and Challenges in Nanocarrier-Based Biofilm Therapy

Product details

  • Edition: 1
  • Latest edition
  • Published: April 1, 2027
  • Language: English

About the editors

NM

Neeraj Mishra

Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has over 20 years of teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for disease. His formulations and controlled delivery approaches are aimed at improving therapeutic outcomes. Dr. Mishra has supervised postgraduate and doctoral research scholars, has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He has won several awards including Outstanding Scientist Award, and Distinguished Professor Award. He is associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, and research. He has been recognized internationally for his research impact and scholarly contributions.

Affiliations and expertise
Professor and Head of Department, Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Gwalior, Madhya Pradesh, India

KA

Kuttiappan Anitha

Dr. Kuttiappan Anitha is working as Assistant Professor in School of Pharmacy and Technology Management (SPTM), SVKM's Narsee Monjee Institute of Management Studies (NMIMS) Deemed-to-University, Shirpur. She has broad teaching and research experience. Dr. Anitha is recipient of “Excellence in Academic Award” 2022 from International School of Technology and Sciences Affiliated from Govt. of India. She has guided more than 45 M.Pharm students and more than 10 batches of UG Projects. She has more than 30 publications in both national and international journals. Her area of expertise includes Immunooncology, endocrine areas, Gut Microbiota, infectious Diseases. She has also written several books and many book chapters. She has organized Conferences/seminars at university levels.

Affiliations and expertise
Institute of Management Studies, India

SA

Sumel Ashique

Dr. Sumel Ashique has been working as an assistant professor at the Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, West Bengal, India. He has 5 years of teaching experience. He has achieved 100+ publications in international and national accredited reputed journals. He has expertise in drug delivery, nanotechnology, and targeted treatment strategies. Recently, he was honored to be in the World’s Top 2% Scientists by prestigious Stanford University, CA, United States, and Elsevier in 2025.

Affiliations and expertise
Department of Pharmaceutical Technology, School of Health and Medical Sciences, Adamas University, Kolkata, West Bengal, India